On the socialization page Virtual Hospital for Children, the pediatrician explains in detail how things are in young adults who are inexplicably killed by COVID-19: –
Many “experts” in COVID-19 loudly claim that the disease is a fad and that it is not vaccinated because the natural immunity (obtained by the disease) is superior to that of the vaccine.
This article (published in one of the most prestigious scientific journals in the world) shows the existence of autoantibodies, which neutralize interferon, in severe forms of SARS-CoV-2 disease https: //www.science.org/doi/10.1126/sciimmunol.abl4340–
90% of those infected with the new coronavirus have mild or asymptomatic forms. But 10% develop pneumonia and, of these, about 2%, severe respiratory failure. At first it was believed that the 10% are selected only from the elderly or with comorbidities. That’s until deaths from intubated young adults began to occur.
What about young people who die inexplicably? One of the main mechanisms is a genetic abnormality. That is, they lack some of the genes responsible for the correct immune response to a viral infection. These patients will produce autoantibodies that block the “ammunition” we use to fight viruses, called intercom. As if an incompetent general ordered the use of training ammunition for real warfare.
The conclusion? Those who die inexplicably due to serious complications of COVID-19 do not have a more severe infection due to SARS-CoV-2 but have a wrong “strategy” of defense, producing autoantibodies that harm their own body, blocking interferon that could prevents the virus from multiplying. This aberrant autoantibody response is present in ~ 1 in 5 patients with severe disease.
If you get the disease and have this type of immune abnormality, you “commit suicide.” If these patients are vaccinated they do not die because autoantibodies do not favor the enemy that would multiply in their body, because the enemy does NOT EXIST!
We also recommend:
–
If you like this article, we expect you to join the community of readers on our Facebook page, with a Like below:
.
